BioCentury
ARTICLE | Clinical News

Isolagen starts facial wrinkle Phase IIIs

July 21, 2004 7:00 AM UTC

ILE began two double-blind, placebo-controlled U.S. Phase III trials of its Isolagen Process autologous injectable cellular therapy to treat facial wrinkles. Each trial will enroll up to 100 patients,...